Delivery Order SPE2DE21D0007-SPE2D625F4ALT
- Not listed
- Ortho-Clinical Diagnostics, Inc. has been awarded a delivery order valued at $794,067.40 by the Defense Health Agency for orthovision supplies, reagents, and maintenance services in support of orthopedics clinical diagnostics. Issued on September 30, 2024, with an ultimate completion date of September 30, 2028, this firm fixed-price contract represents an unrestricted competitive award with no set-aside designation. The work will be performed at the company's headquarters in Raritan, New Jersey....
- Ortho-Clinical Diagnostics, Inc. was awarded a firm fixed-price delivery order valued at $193.4K by the Defense Health Agency on March 26, 2024, for cost-per-test reagents, equipment, and service related to Ortho Vision Analyzers. The contract, which extends through September 30, 2026, will be performed at the contractor's facility in Raritan, New Jersey. This delivery order was issued without a set-aside designation, indicating open competition, and is structured under the Critical Analyzers,...
- Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, was awarded a delivery order contract valued at $81,552.60 on October 23, 2020, by the Defense Department's Medical Supply Chain for the supply of diagnostic medical equipment and related services. The contract, which employed firm fixed-price pricing with no set-aside designation, was scheduled for completion by November 5, 2020, and is to be performed in Raritan, New Jersey. This delivery order represents a continuation of...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order contract on July 11, 2025, by the Medical Supply Chain division of the Department of Defense for the supply of Anti-A Bioclone 15x10ml reagents, valued at $1,156.61. The contract employs fixed-price pricing with economic price adjustment provisions and is scheduled for ultimate completion by August 1, 2025. The work will be performed at the company's facility in Raritan, New Jersey. No set-aside designation was used in this...
- This is a $90,000.00 fixed-price delivery order awarded by the Defense Health Agency, a component of the U.S. Department of Defense, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the provision of an ORTHO VISION ANALYZER, a type of medical diagnostic equipment. The award has an ultimate completion date of September 3, 2024. Ortho-Clinical Diagnostics, Inc. has provided medical equipment, reagents, consumables, and testing services to...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $1,335.20 to Ortho-Clinical Diagnostics, Inc. on May 30, 2025, for ortho-clinical diagnostic solutions and enhanced orthopedic supplies. This firm fixed-price delivery order, which is due for completion by June 4, 2025, was awarded without set-aside designation, indicating open competition. The contract will be performed at the awardee's facility in Raritan, New Jersey. Ortho-Clinical Diagnostics, Inc. is a...
- This is a delivery order awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer located in Raritan, New Jersey. The contract is for the provision of Ortho Vision reagents and consumables for the period of October 1, 2023 to September 30, 2024, with a ceiling value of $145,319.06. The contract is a firm fixed-price delivery order, and no set-aside designation was used. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 22, awarded a $1,580,171.67 firm fixed price delivery order contract to Ortho-Clinical Diagnostics, Inc. for a dry chemistry immunochemistry system. The contract has a completion date of March 31, 2026 and does not have a set-aside designation. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides a range of diagnostic solutions, including immunodiagnostic and clinical chemistry systems, to...
- This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the provision of Ortho Vision laboratory consumables and supplies. The contract has a ceiling value of $249,797.77 and a period of performance ending on March 30, 2021. It is issued under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule, indicating the company's specialized capabilities in medical diagnostic...
- Ortho-Clinical Diagnostics, Inc. has been awarded a delivery order valued at $456,420 by the Defense Health Agency for an analyzer and associated reagents, with performance to be completed by September 30, 2026. The contract, which became effective October 1, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competition among qualified vendors. Work will be performed at the company's facility in Raritan, New Jersey. As a leading medical...
- SPE2DE21D0007Indefinite Delivery Contract
- SPE2DE21D0007-SPE2D625F4ALTDelivery Order
Ortho-Clinical Diagnostics, Inc. was awarded a $180,000 delivery order by the Defense Department's Medical Supply Chain entity on September 22, 2025, for an Ortho Vision Analyzer with an ultimate completion date of November 26, 2025. The contract employs fixed-price pricing with economic price adjustment provisions and carries no set-aside designation, indicating open competition. Performance will occur at the company's Raritan, New Jersey headquarters, where the firm manufactures specialized diagnostic equipment and reagents for federal healthcare systems. Ortho-Clinical Diagnostics is a for-profit medical equipment manufacturer and self-certified HUBZone joint venture that specializes in providing advanced laboratory diagnostic solutions to federal agencies. The company holds multiple significant indefinite delivery vehicles, including a $1.64 million Indefinite Delivery Contract with Veterans Integrated Service Network 12 for Ortho Vision Analyzer reagents and services, which this delivery order likely supports. As a primary supplier to federal healthcare entities including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and National Institutes of Health, the company maintains GSA Schedule contracts that facilitate delivery of critical laboratory testing infrastructure across multiple federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $180.0k | 9/22/25 |